D. Ramzy, Los angeles, CA, United States of America
Cedars Sinai Medical CenterPoster Author Of 6 e-Posters
893 - Does a Redo Heart Transplant Decrease the Chance for Primary Graft Dysfunction?
Presentation Number
893
Session Name
PO-2-HTX - Poster Session 2: Heart Transplantation
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- F. Esmailian, Los Angeles, CA, United States of America
- B. Kearney, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
1087 - Liver Fibrosis Predicts Survival After Heart Transplant
Presentation Number
1087
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- K. Nguyen, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
- T. Tran, Los Angeles, CA, United States of America
1131 - Pathology Antibody-Mediated Rejection Plus Circulating Donor-Specific Antibodies Increase Development of Cardiac Allograft Vasculopathy After Heart Transplantation
Presentation Number
1131
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- R. Bleiker, Los Angeles, CA, United States of America
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- D. Geft, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- N. Lam, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- D. Luthringer, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1134 - Is First-year DSA After Heart Transplantation Truly a Biomarker for the Development of Cardiac Allograft Vasculopathy?
Presentation Number
1134
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- M. Curry, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- A. Hage, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Olive, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1135 - Does ATG Induction Prevent Donor-specific Antibodies After Heart Transplantation?
Presentation Number
1135
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- A. Hage, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- K. Norland, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
1167 - Low Correlation Between PCWP and LVEDP in Patients With End-Stage Lung Disease
Presentation Number
1167
Session Name
PO-3-LTX - Poster Session 3: Lung Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- G. Chaux, Los angeles, CA, United States of America
- W. Cheng, Los angeles, CA, United States of America
- J. Falk, Los angeles, CA, United States of America
- A. Kafi, Los angeles, CA, United States of America
- B. Lindgren, Los angeles, CA, United States of America
- J. Mirocha, Los angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
Questions about ePosters? Contact CTI Meeting Technologies Technical Support at ishlt@support.ctimeetingtech.com or 217-398-1792.
Questions about the "ISHLT 38th Annual Meeting and Scientific Sessions"? Contact communications@ishlt.org.
CTI Meeting Technologies© All Rights Reserved.